Papers
Topics
Authors
Recent
Search
2000 character limit reached

Adaptive Protein Tokenization

Published 6 Feb 2026 in cs.LG and q-bio.BM | (2602.06418v1)

Abstract: Tokenization is a promising path to multi-modal models capable of jointly understanding protein sequences, structure, and function. Existing protein structure tokenizers create tokens by pooling information from local neighborhoods, an approach that limits their performance on generative and representation tasks. In this work, we present a method for global tokenization of protein structures in which successive tokens contribute increasing levels of detail to a global representation. This change resolves several issues with generative models based on local protein tokenization: it mitigates error accumulation, provides embeddings without sequence-reduction operations, and allows task-specific adaptation of a tokenized sequence's information content. We validate our method on reconstruction, generative, and representation tasks and demonstrate that it matches or outperforms existing models based on local protein structure tokenizers. We show how adaptive tokens enable inference criteria based on information content, which boosts designability. We validate representations generated from our tokenizer on CATH classification tasks and demonstrate that non-linear probing on our tokenized sequences outperforms equivalent probing on representations from other tokenizers. Finally, we demonstrate how our method supports zero-shot protein shrinking and affinity maturation.

Summary

  • The paper presents a global tokenization strategy that incrementally encodes protein structures using a diffusion autoencoder and a coarse-to-fine token hierarchy.
  • It leverages nested dropout and finite-scalar quantization to generate fixed-size, adaptive embeddings, achieving competitive reconstruction metrics on standard benchmarks.
  • The approach enables zero-shot protein shrinking and affinity maturation, showcasing practical advances in scalable, generative protein modeling.

Adaptive Protein Tokenization: A Technical Perspective

Motivation and Paradigm Shift

This paper addresses the limitations inherent in locality-based tokenization schemes for protein structures, which pool spatially proximal information per token and thus scale linearly with sequence length. Such approaches introduce error accumulation in generative frameworks and impose computational inefficiencies for large proteins and complexes. The authors propose the Adaptive Protein Tokenizer (APT), adopting a global tokenization strategy wherein each token incrementally encodes finer levels of global structural information. This coarse-to-fine hierarchy parallels signal decomposition techniques—such as Fourier and wavelet transforms—offering a compressible, task-adaptive representation.

APT utilizes a diffusion autoencoder with a discrete bottleneck. Crucially, nested dropout enforces adaptivity: early tokens capture low-frequency, global descriptors while additional tokens encode high-frequency structural details. The model's architecture—bidirectional attention transformer with finite-scalar quantization (FSQ) and diffusion decoder trained via flow matching—eschews explicit symmetry biases. The system decouples sequence length from representation length, enabling fixed-size embeddings and applications such as protein shrinking and affinity maturation.

Technical Contributions and Methodology

APT accomplishes several distinct technical objectives:

  • Global Token Representation: Each token provides incremental detail to a global protein representation, shifting away from spatial neighborhood pooling.
  • Diffusion-Based Encoder-Decoder: The encoder maps normalized backbone coordinates to latent vectors, discretized via FSQ. The diffusion decoder, conditioned on these tokens, reconstructs the 3D structure using a flow-matching objective. Model training incorporates random rotational augmentations to encourage stochastic equivariance.
  • Adaptive Compression via Nested Dropout: Uniformly sampled tail cutoffs enable variable-length, adaptive tokenization, forcing critical information into the leading tokens. This architecture supports arbitrary prefix truncation at inference, facilitating compression and adjustable reconstruction fidelity.
  • Information Content-Based Inference: Token entropy heuristics inform sampling cutoffs, trading off sample complexity against error exposure and enabling principled exploration/exploitation behaviors during generative rollout.
  • Zero-shot Structural Manipulations: Decoupling size from conditioning supports tasks like zero-shot shrinking and affinity maturation, where protein length or functional affinity is manipulated at inference.

Empirical Evaluation

Reconstruction

APT achieves RMSD and TM-score metrics comparable to or outperforming state-of-the-art models (e.g., DPLM2, ESM3, Kanzi) on held-out CATH, CAMEO, and AFDB datasets. Performance with full-length conditioning is competitive with locality-based tokenizers; substantial compression (e.g., 32–128 tokens for large proteins) retains sufficient accuracy for downstream generative tasks, demonstrating effective structure compactness.

Generation

Autoregressive models trained on APT tokens outperform discrete diffusion and structure-tokenizer-based autoregressive models in designability—0.871 vs 0.562 for Kanzi and 0.486 for DPLM2—while achieving superior scRMSD scores. Classifier annealing further boosts designable sample rates (>80%), with entropy-based token sampling enabling dynamic fidelity-adjustments. The global tokenization prevents repeated tokens during rollout and mitigates error propagation, increasing robustness. The model also supports tailored inference via flexible stopping based on entropy minima, spline fitting, or fixed cutoffs.

Representation Learning

APT tokens provide fixed-size, globally informative embeddings, facilitating downstream tasks without mean-pooling—a common source of information loss in variable-length protein representations. MLP probing substantially outperforms local tokenizers (DPLM2, ESM3) on CATH classification, especially with highly compressed global tokens. Linear probes are less effective, reflecting the non-linearity of globally entangled pose and structure.

Applications

Adaptive global tokens enable novel applications:

  • Protein Shrinking: Condition diffusion decoding with reduced sequence lengths, effectively producing smaller, structure-retaining proteins. Empirical TM-scores demonstrate high structural conservation.
  • Affinity Maturation and Beam Search: Arbitrary-length prefixes encode sufficient global context, allowing test-time scaling with external reward functions (e.g., beta sheet content, CATH class prediction, iPAE for binder affinity). Beam search directly operates in latent token space, obviating costly rollouts for reward calculation.

Design Choices and Ablations

Scaling the codebook size (FSQ vocabulary) improves reconstruction performance; increasing encoder depth and width yields ambiguous results, suggesting coupled scaling of encoder, decoder, and codebook is necessary. Size prediction via weak cross-entropy regularization from the first token yields high accuracy with minimal impact on flow optimization. Use of absolute positional encodings enhances convergence. RMSD does not invariably correlate with flow loss, indicating potential suboptimality in the noise schedule.

Implications and Future Directions

APT marks a departure from sequence-length dependency to global, adaptive compression, presenting substantial implications for scalable modeling of large protein complexes and multimodal protein tasks. The approach allows for smooth information content tuning matching task complexity, from low-resolution fields (e.g., CryoET) to precision binder design.

There are caveats: global tokens are less suited for local motif tasks; coverage must be balanced with exploration of structural diversity. The system lacks explicit sidechain and sequence-awareness, limiting functional and local motif manipulations. Integrating global and local representations, and extending adaptive tokenization across modalities (sequence, structure, function) is a natural progression for AI-driven bioengineering.

Practically, the approach reduces computational burden for large protein systems, supports rapid, flexible inference, and facilitates direct integration with downstream experimental workflows (e.g., inverse folding, structure-based drug design).

Conclusion

Adaptive Protein Tokenizer offers a generalized, adaptive tokenization methodology for protein structures, demonstrating competitive and often superior performance in reconstruction, generation, and representation learning tasks compared to locality-based approaches. The global, coarse-to-fine token hierarchy is crucial for scalable, information-efficient generative modeling, yielding practical advances in protein compression and search-based design tasks. Future work should focus on multimodal integration, cross-scale reasoning, and further task-specific adaptivity to fully leverage the potential of global tokenization frameworks (2602.06418).

Paper to Video (Beta)

Whiteboard

No one has generated a whiteboard explanation for this paper yet.

Ai Sparkles Streamline Icon: https://streamlinehq.com Sign Up to Generate

Explain it Like I'm 14

What is this paper about?

This paper introduces a new way to “turn” 3D protein shapes into short, discrete symbols called tokens, so that AI models can better understand and generate proteins. Instead of describing small local pieces one-by-one, the new method—called APT (Adaptive Protein Tokenizer)—builds a global summary of the whole protein step by step, like starting with a rough sketch and then adding finer details.

What were the researchers trying to do?

The team asked a few simple questions:

  • Can we design tokens that summarize the whole protein first, then add detail, so we need fewer tokens for big, simple proteins?
  • Will this global, coarse-to-fine approach make AI protein generators more accurate and stable than older “local” token methods?
  • Can we adapt how many tokens we use based on how complex the protein is?
  • Do these tokens make good fixed-size “fingerprints” for other tasks, like classifying protein families?
  • Can this approach enable new tricks, like shrinking a protein while keeping its overall shape?

How did they do it? (In everyday language)

Think of the process like compressing and then rebuilding a 3D object:

  • Tokenization as a dictionary: The model learns a “dictionary” of discrete codes (tokens). Each token represents information about the protein’s overall shape, not just one tiny neighborhood. Early tokens capture the big picture; later tokens refine details.
  • Coarse-to-fine hierarchy: It’s like drawing a map: first you sketch the outline (global shape), then add roads (medium details), then street names (fine details). Each new token increases the detail of the same whole map.
  • Autoencoder with diffusion:
    • Autoencoder = compressor + decompressor. The encoder compresses a protein into tokens. The decoder reconstructs the 3D shape from those tokens.
    • Diffusion decoder = cleaning a blurry image: The decoder starts from noisy coordinates and repeatedly “denoises” them into a realistic protein shape, guided by the tokens.
  • Discrete tokens (FSQ): They use a simple quantization method that turns continuous numbers into a small set of levels—like rounding to the nearest “tick mark”—so tokens are discrete and easy for language-like models.
  • Adaptive tokens via nested dropout: During training, the model is often forced to reconstruct using only the first few tokens. This nudges it to put the most important global info up front and the fine details later. That way, you can choose how many tokens you need based on the task.
  • Size prediction: The first token also predicts how long the protein should be. Size is a global property, so it fits naturally in the early tokens.
  • Two training stages: 1) Train the autoencoder (compress + reconstruct shapes). 2) Train an autoregressive model (like GPT) to generate token sequences, then use the diffusion decoder to turn those tokens into 3D proteins.
  • Smarter sampling at generation time:
    • Tail token dropout: If later tokens might add small but harmful errors, you can drop them and let the diffusion decoder fill in the fine details safely.
    • Entropy-based stopping: “Entropy” here means how unsure the model is. If uncertainty rises, you can stop adding tokens and let the decoder finish the job, balancing detail and reliability.
    • Classifier annealing: A gentle way to steer the decoder between “following the prompt closely” and “sticking to the most realistic shapes,” reducing weird artifacts.

What did they find?

Here are the main results and why they matter:

  • Strong reconstructions with fewer tokens:
    • Using all tokens, APT reconstructs proteins about as well as the best existing models.
    • Even using fewer tokens (like 32–64), it keeps the shape accurate enough for good generation. This shows big proteins can be compressed efficiently.
  • Better or matching generation quality:
    • When they generate new proteins from tokens, APT matches or beats other token-based methods and approaches the quality of top diffusion models.
    • Using tail dropout, entropy-based stopping, and classifier annealing can greatly improve “designability” (how often the generated structure is plausible and stable).
  • Useful fixed-size representations for classification:
    • Because early tokens summarize global shape, you can take a fixed number (e.g., 16) for every protein as a compact “fingerprint”—no averaging across residues needed.
    • On a standard test (CATH classification), a small neural probe on these tokens outperformed similar probes on other tokenizers for global tasks.
  • New applications:
    • Protein shrinking: They can reuse the same global tokens but ask the decoder for a shorter protein. The result keeps much of the original fold, showing a path to smaller, potentially more usable proteins in medicine.
    • Affinity maturation/test-time scaling: They can start from an initial token prefix and explore variations while optimizing simple rewards (like more beta sheets or belonging to a target class), without always doing expensive full runs.
  • Practical trade-offs you can control:
    • Fewer tokens = higher per-sample quality but less diversity.
    • More tokens = more diverse structures but slightly higher risk of errors.
    • Entropy-based stopping and tail dropout let you dial in the balance for your task.
  • Noted limitations:
    • Best for global tasks, less suited for very local motifs.
    • The tokenizer focuses on backbones (not sidechains), so functional details that depend on specific amino acids aren’t directly modeled.

Why does this matter, and what could it lead to?

  • Scales better to big proteins: Because tokens carry global info, you don’t need a token for every residue. That means faster models and the ability to handle large proteins and complexes.
  • More stable generation: The coarse-to-fine design reduces “error snowballs” that used to happen when one wrong local token messed up its neighbors.
  • Flexible for many tasks: You can choose how many tokens to use based on how much detail you need. This is helpful for everything from low-resolution tasks (like some imaging data) to precise design problems.
  • Better building blocks for multi-modal biology: These tokens can be combined with sequence or text descriptions (functions) to build richer models that connect sequence, structure, and function.
  • Future directions:
    • Combine global and local tokens for full control across scales.
    • Add sidechain and chemical info for function-level design.
    • Use APT in larger, multi-modal systems to design enzymes, binders, or therapeutics more reliably.

In short, APT makes protein “language” more compact, more adaptable, and more useful for both understanding and creating protein structures, opening doors to faster and smarter protein engineering.

Ai Sparkles Streamline Icon: https://streamlinehq.com View Paper Prompt  List Streamline Icon: https://streamlinehq.com View All Prompts 

Knowledge Gaps

Knowledge gaps, limitations, and open questions

Below is a concise, actionable list of what remains missing, uncertain, or unexplored in the paper, to guide future research.

  • Data realism and coverage:
    • Trained primarily on ~473k AlphaFold2-predicted structures (AFDB), not experimental PDB structures; unclear generalization to experimentally determined (and noisier) structures and to membrane proteins, multi-domain proteins, and intrinsically disordered proteins (IDPs).
    • Single-chain focus; no demonstration on multi-chain assemblies, quaternary structure, or protein–protein complexes where cross-chain geometry and stoichiometry matter.
    • Limited assessment of out-of-distribution performance (e.g., novel folds, repeat proteins, very long proteins >1000 residues, membrane/secreted proteins, metalloproteins).
  • Representation scope:
    • Backbone-only, CαC_\alpha-coordinate tokenizer; no sidechain or sequence identity modeling. It is unclear how well APT supports sequence–structure co-generation, sidechain packing, active-site geometry, metal coordination, disulfide bonds, or post-translational modifications.
    • Lack of multi-modal integration (e.g., natural language/function annotations or sequence tokens) despite tokenization’s stated multi-modality motivation.
  • Symmetry and pose handling:
    • Decoder is not explicitly SE(3)SE(3)-equivariant and relies on stochastic equivariance via augmentation; the entanglement of pose and structure degrades linear separability in probing. Open question: does explicit equivariance (or hybrid approaches) improve representation linearity and generalization?
    • Use of absolute positional encodings rather than RoPE or relative schemes for the encoder—impact on length generalization, extrapolation to much longer proteins, and stability remains untested.
  • Token interpretability and hierarchy:
    • The “coarse-to-fine” claim (global-to-local) is conceptual; no quantitative or interpretability analysis linking token indices to spectral content, structural length scales, or defined geometric features (e.g., secondary/tertiary motifs).
    • No diagnostic probing to verify whether early tokens predominantly capture low-frequency/global properties and late tokens capture high-frequency/local details.
  • Adaptive token budget selection:
    • Heuristics for token cutoff (fixed, finite-entropy, spline minimum) are empirical; no principled procedure for choosing token budgets per task or per-sample complexity, nor calibration of token entropy to predictive uncertainty or information content.
    • Lack of theoretical or empirical analysis on how per-token entropy correlates with downstream error, designability, or structural fidelity across protein classes.
  • Reconstruction objective and training dynamics:
    • Observed mismatch between decreasing flow loss and increasing RMSD suggests suboptimal noise schedule or objective; no exploration of alternative schedules, loss weightings, or flow/diffusion parameterizations to align proxy loss with geometric metrics.
    • Limited analysis of codebook utilization (e.g., dead codes), stability of FSQ discretization, and comparisons to learned vector quantization (e.g., VQ-VAE) at larger vocabularies.
  • Scaling and efficiency:
    • Claims of improved scaling not backed by experiments on very large proteins/complexes or benchmarks of memory/latency vs local tokenizers; no end-to-end cost analysis for AR prior + diffusion decode vs continuous diffusion baselines.
    • Maximum token cap (kmax⁡=128k_{\max}=128) is not justified for broader settings; unclear behavior if kmax⁡k_{\max} is increased or when decoding very long chains.
  • Generative fidelity vs diversity:
    • “Classifier annealing” improves designability but risks posterior collapse; no systematic characterization of collapse onset, fold preservation across α\alpha schedules, or principled selection of guidance/annealing schedules per task.
    • The trade-off between token dropout (reducing error exposure) and distributional coverage is only partially quantified; no Pareto front or task-dependent guidelines.
  • Evaluation breadth and fairness:
    • Generative evaluation relies on computational metrics (designability, scRMSD, TM-score, rFID/gFID) without wet-lab validation or physics-based assessments (e.g., Rosetta energy, MD stability).
    • Comparisons to ESM3/DPLM2/Kanzi may be confounded by differences in training data, modalities, or compute; no standardized, equal-footing benchmark protocol is established.
    • Representation learning evaluated mainly on CATH global classification; missing tests on diverse downstream tasks (e.g., stability, solubility, mutational effect prediction) and on local tasks (where authors note current weakness).
  • Local vs global reasoning:
    • Acknowledged limitation for local tasks (e.g., motif scaffolding, active-site geometry), but no concrete multi-scale mechanism that unifies global tokens with local, high-resolution control.
    • No experiments combining APT tokens with residue-level features or hierarchical token stacks to support both global topology and fine-grained motif constraints.
  • Sequence and function coupling:
    • No demonstration of joint sequence–structure generation or sequence design conditioned on APT tokens (e.g., compatibility with ProteinMPNN-style sequence recovery or co-design loops).
    • No integration of function tokens (text or assays) or demonstration of function-conditioned structure generation, despite citing multi-modal ambitions.
  • Size prediction and decoupling:
    • Protein size is regressed from the first token(s); robustness under distribution shift (unusual lengths/topologies) and its failure modes are not analyzed. Impact of size prediction error on decode quality and generation remains unclear.
  • Application prototypes need validation:
    • Zero-shot shrinking shows geometric similarity but lacks sequence redesign, energy/stability evaluation, or functional assays; practical viability is untested.
    • Affinity maturation demonstrations rely on proxy rewards and beam search without docking, binding-energy estimation, or experimental assays; generality, convergence, and compute cost not characterized.
  • Robustness and edge cases:
    • No examination of robustness to missing residues, chain breaks, nonstandard residues, ligands/cofactors, or experimental noise; decoding stability under such practical conditions is unknown.
    • Behavior on highly flexible/IDP regions and multi-domain linkers is not reported; reconstruction and generation may degrade for disordered or multi-state proteins.
  • Theory and guarantees:
    • No theoretical characterization of error propagation in AR token prediction under nested dropout, or bounds relating token count/entropy to reconstruction error or designability.
    • Lack of formalism connecting the global token hierarchy to information-theoretic quantities (e.g., rate–distortion trade-offs) to guide adaptive compression.
  • Future integration:
    • How to incorporate APT tokens into larger multimodal models (sequence, structure, text) and whether APT improves over local tokenizers in such settings remains an open question.
    • Strategies for combining APT with continuous diffusion backbones (e.g., hybrid decoders, multi-scale guidance) to improve both fine-grained control and global coherence are unexplored.
Ai Sparkles Streamline Icon: https://streamlinehq.com View Paper Prompt  List Streamline Icon: https://streamlinehq.com View All Prompts 

Practical Applications

Immediate Applications

Below is a concise list of practical, deployable uses that can be implemented with the paper’s current methods and findings, organized by sector where relevant.

  • Adaptive in-silico protein generation with quality–diversity control
    • Sector: biotech, pharmaceuticals, software
    • What: Use APT’s entropy-based token cutoffs and tail dropout to mitigate error exposure during autoregressive generation; combine with classifier annealing to increase designability while preserving fold adherence.
    • Tools/workflows: Integrate an “APT-Design” module into existing structure-generation stacks; add knobs for token cutoff, entropy threshold, and classifier annealing schedule.
    • Assumptions/dependencies: Works on backbone Ca coordinates; requires downstream sequence recovery (e.g., ProteinMPNN) and wet-lab validation for function; computational cost from diffusion/O(D,E) sampling persists.
  • Fixed-length global protein embeddings for fast property prediction
    • Sector: biotech, pharma R&D, academia, software (MLops)
    • What: Replace variable-length residue features and mean pooling with fixed-length APT prefixes for global property prediction (e.g., CATH classification, solubility, thermostability).
    • Tools/workflows: “APT-Embed” API for encoding proteins to RN×K token space and training lightweight MLP probes; pluggable into AutoML pipelines and dashboards.
    • Assumptions/dependencies: Non-equivariant encoder entangles pose and structure; linear probes underperform—use non-linear probes; trained on AFDB synthetic structures, so generalization to experimental structures should be checked.
  • Token-space verifiers for rapid screening without full decodes
    • Sector: biotech, computational chemistry
    • What: Build classifiers/regressors that operate directly on discretized token sequences to score properties (fold class, secondary structure content, coarse binding proxies) faster than repeated diffusion decodes.
    • Tools/workflows: “TokenSpace-Verify” library for beam search scoring during test-time scaling; integrate with reward-driven generation.
    • Assumptions/dependencies: Token-space surrogates approximate physical properties; high-stakes decisions still require full structure decode and physics-based or ML docking/scoring.
  • Affinity maturation via test-time scaling and beam search
    • Sector: biotech, therapeutic discovery
    • What: Prefill generation with the token prefix of a weak binder, then continue generation under external reward functions (e.g., token-space verifiers, secondary structure targets).
    • Tools/workflows: “BeamBinder” inference workflow combining AR token generation, beam search, and reward tracing; triage candidates for lab testing.
    • Assumptions/dependencies: Binding affinity is highly sidechain-dependent; requires sequence design and experimental validation; reward functions should be calibrated to avoid mode collapse.
  • Zero-shot protein shrinking (in silico)
    • Sector: biotech, diagnostics, delivery
    • What: Condition diffusion on smaller sizes while reusing the same global conditioning tokens to produce shorter variants that preserve high-level folds.
    • Tools/workflows: “ShrinkLab” pipeline for size regression from initial tokens, decode under reduced length, and prioritize candidates by TM-score and geometric constraints.
    • Assumptions/dependencies: Sidechain chemistry and function are not modeled in APT; shrinking is a structural proof-of-concept requiring subsequent sequence optimization and wet-lab validation; consider immunogenicity and stability.
  • Task-aware token budgeting to match data resolution
    • Sector: structural biology (cryo-EM/cryoET), academic labs
    • What: Choose fewer tokens for low-resolution tasks (e.g., cryoET density fitting), more tokens for high-resolution scaffold tasks; explicitly trade off exploration vs exploitation.
    • Tools/workflows: “Resolution-aware generation” presets that map instrument/assay resolution to token count and classifier annealing schedule.
    • Assumptions/dependencies: Requires calibration per task; low-token decodes improve single-sample quality but reduce distributional coverage.
  • Structure search, indexing, and compression using discrete token prefixes
    • Sector: software, databases, IP analytics
    • What: Use FSQ-based codebooks and fixed-length token prefixes to index structures for fast nearest-neighbor search, deduplication, and compressed storage.
    • Tools/workflows: “APT-Index” service for token-based retrieval; vector search over discrete embeddings; structure cataloging and versioning.
    • Assumptions/dependencies: Index quality depends on codebook granularity; AFDB-derived training may bias embeddings toward predicted, not experimental structures.
  • Educational and training resources for hierarchical protein representations
    • Sector: education, academia
    • What: Use coarse-to-fine token hierarchies to teach protein structure concepts; visualize how added tokens refine global content.
    • Tools/workflows: Interactive notebooks, teaching modules showcasing reconstructions at 16/32/64 tokens and entropy cutoffs.
    • Assumptions/dependencies: Pedagogical use is safe, but avoid enabling novice misuse in generative bio contexts; align with Responsible AI x Biodesign principles.

Long-Term Applications

These opportunities require additional research, scaling, integration with sequence/sidechain modeling, and experimental validation.

  • Therapeutic miniaturization for better delivery and cell penetration
    • Sector: healthcare, biotech, drug delivery
    • What: Robustly shrink proteins while preserving function to improve tissue penetration, dosing, and manufacturability.
    • Tools/products: “MiniBinder” therapeutics; delivery-optimized enzymes; stabilized scaffolds with reduced length.
    • Assumptions/dependencies: Sidechain-aware modeling and co-generation (sequence + structure); biochemical stability, immunogenicity testing; GMP-scale manufacturing; regulatory approval.
  • Multimodal co-generation of sequence–structure–function with global tokens
    • Sector: biotech, pharma, platform AI
    • What: Train large multimodal models using APT tokens to coordinate sequence text (language), structure, and function annotations; scale to complexes (~103 residues).
    • Tools/products: “APT-MM” foundation models for de novo enzyme and binder design; co-pilot interfaces for scientists.
    • Assumptions/dependencies: Larger, curated datasets beyond AFDB; careful symmetry handling; robust evaluation; safety gating and biosecurity guardrails.
  • CryoEM/cryoET-guided generative refinement and heterogeneous data fusion
    • Sector: structural biology, instrumentation
    • What: Combine classifier annealing with limited-interval guidance to align decodes to experimental densities; adapt token budgets to dataset resolution.
    • Tools/workflows: “Density-guided APT” plugin for cryo pipelines; iterative refinement with reward functions tied to map-fit metrics.
    • Assumptions/dependencies: Access to experimental maps; consistent pre-processing; integration with AlphaFold3/Proxels and downstream validation.
  • Autonomous lab-in-the-loop design agents operating in token space
    • Sector: biotech automation, MLops for wet labs
    • What: Agents that iteratively propose token-space candidates, score with surrogate models, decode promising structures, design sequences, and execute experiments autonomously.
    • Tools/products: “APT-Agent” platforms with robotic execution (HT assays), Bayesian optimization over token prefixes.
    • Assumptions/dependencies: Reliable surrogate models; closed-loop experimental infrastructure; rigorous safety oversight; compute governance.
  • Industrial-scale protein databases and IP analytics powered by token embeddings
    • Sector: software, legal/IP, enterprise analytics
    • What: Ultra-fast structure similarity search, novelty scoring, and patent landscaping via discrete, fixed-length embeddings.
    • Tools/products: “APT-Search” enterprise platform; IP risk dashboards; novelty heatmaps.
    • Assumptions/dependencies: Comprehensive coverage of experimental structures; fairness and bias assessments; legal compliance.
  • Enzyme engineering for sustainability (biocatalysis, biofuels, carbon capture)
    • Sector: energy, industrial biotech, environment
    • What: Design novel enzymes with global functional constraints (stability, activity) using APT-guided generation and token-space screening.
    • Tools/products: Catalysts for plastic degradation, CO2 fixation; process-specific enzymes with tailored size and stability.
    • Assumptions/dependencies: Sequence/function co-design; reaction-condition robustness; scale-up and economic viability; environmental impact studies.
  • Diagnostic assay design and point-of-care binders
    • Sector: healthcare, diagnostics
    • What: Generate compact, stable binders for rapid tests (e.g., lateral flow) using shrinking, affinity maturation, and token-space verifiers for target class recognition.
    • Tools/products: “APT-Diagnostics” kits with designed binders; rapid assay pipelines.
    • Assumptions/dependencies: Lab validation for specificity/sensitivity; cold-chain and shelf-life constraints; regulatory pathways.
  • Safety tooling and governance for generative biology
    • Sector: policy, governance, compliance
    • What: Use token entropy and information-content thresholds as gating mechanisms; audit token sequences; implement controlled access tiers for high-capability decoders.
    • Tools/workflows: “APT-Safe” policies (rate-limits, content filters), audit logs tied to token prefixes, human-in-the-loop review.
    • Assumptions/dependencies: Institutional buy-in; harmonization with Responsible AI x Biodesign; threat modeling; oversight mechanisms.
  • Personalized medicine pipelines
    • Sector: healthcare, precision medicine
    • What: Propose patient-specific binders/enzyme variants with APT-guided generation and token-space screening against patient omics/structure data.
    • Tools/products: Personalized binder design workflows; therapeutic variant libraries.
    • Assumptions/dependencies: Integration with clinical data; ethical, privacy, and regulatory frameworks; extensive validation and safety monitoring.

Cross-cutting assumptions and dependencies

  • Sidechain and sequence dependence: APT operates on Ca backbones; practical function requires sequence design and sidechain-aware modeling.
  • Data provenance: Training on AFDB (AlphaFold2 predictions) introduces distributional shifts relative to experimental structures; validation against high-quality experimental datasets is needed.
  • Computational resources: Diffusion decoding is compute-intensive; production use may require batching, caching, or token-space surrogate filters to manage cost.
  • Safety and biosecurity: Generative biology must adhere to Responsible AI x Biodesign; enforce access controls, audits, and human oversight.
  • Generalization and robustness: Non-equivariant encoder may reduce linear separability; prefer non-linear probes and task-specific calibration; larger codebooks improve reconstruction but must be tuned jointly with model size and data scale.
Ai Sparkles Streamline Icon: https://streamlinehq.com View Paper Prompt  List Streamline Icon: https://streamlinehq.com View All Prompts 

Glossary

  • Adaptive tokenization: A tokenization strategy where the number or content of tokens adjusts to the complexity of the input, prioritizing global information early. "We introduce an adaptive diffusion-based tokenizer for biological structure in which tokens represent global descriptors rather than local neighborhoods."
  • Affinity maturation: The process of iteratively improving a protein's binding strength to a target, often via design or selection. "We demonstrate how our method supports zero-shot protein shrinking and affinity maturation."
  • AFDB: The AlphaFold Protein Structure Database containing predicted protein structures at scale. "We train on synthetic AlphaFold2 predictions from the Foldseek clustered AFDB database."
  • AlphaFold2: A deep learning model for predicting protein structure from sequence with high accuracy. "Early works relied heavily on SE(3) invariant losses and architectures derived from seminal protein folding work in AlphaFold2 (Jumper et al., 2021)."
  • Autoregressive model: A model that generates sequences token by token, conditioning each step on previously generated tokens. "Second, we train GPT-style autoregressive models over APT tokens to evaluate generative capabilities."
  • Beta sheet: A common protein secondary structure formed by beta strands connected laterally by hydrogen bonds. "We increase beta sheet content."
  • CAMEO: A benchmarking dataset for protein structure prediction and modeling. "We use three held-out test datasets: CAMEO, a subset of CATH, and a subset of the AFDB."
  • CATH: A hierarchical classification system for protein domain structures (Class, Architecture, Topology, Homologous superfamily). "We validate representations generated from our tokenizer on CATH classification tasks."
  • Ca coordinates: The 3D positions of alpha-carbon atoms along a protein backbone, used to represent structure. "We take as input a length L sequence of raw Ca coordinates normalized to have zero-mass."
  • Classifier annealing: Interpolating guidance between conditional and unconditional models during diffusion to balance fidelity and realism. "Classifier annealing compensates and uniformly improves designability."
  • Classifier-free guidance: A diffusion guidance technique that balances conditional and unconditional scores to improve adherence to prompts. "Prior works have observed that while classifier-free guidance leads to better prompt adherence, shifting away from the true data manifold can lead to artifacts."
  • Codebook: The discrete set of token values into which continuous inputs are quantized. "A common paradigm to generate continuous data is to train a tokenizer, which maps continuous inputs to a finite, discrete codebook."
  • Designability: The fraction of generated structures that are viable or meet target criteria under evaluation. "This combines limited intervals and manifold constrained guidance (Kynkäänniemi et al., 2024; Chung et al., 2024), and generalizes a late-stage refinement step used in several works (Faltings et al., 2025; Raghu et al., 2025). We parameterize classifier annealing as follows..."
  • Diffusion autoencoder: An autoencoder where reconstruction is performed via a conditioned diffusion process rather than deterministic decoding. "In a diffusion autoencoder, a model encodes data to a sequence of tokens which condition a generative diffusion process."
  • Diffusion decoder: The generative component that reconstructs continuous data by integrating a diffusion (or flow) process conditioned on tokens. "use these tokens to condition a diffusion decoder trained using a flow-matching objective"
  • Diffusion transformer (DiT): A transformer architecture adapted for diffusion-based generative modeling. "We build our tokenizer using a scalable diffusion transformer architecture"
  • Discrete diffusion: Diffusion models operating over discrete token spaces rather than continuous variables. "We compare against discrete diffusion models (DPLM2, ESM3)"
  • Entropy cutoff sampling: A generation strategy that truncates token sequences when per-token entropy exceeds a threshold. "In entropy cutoff sampling, we sample tokens up to a fixed per-token entropy value."
  • Equivariance (stochastic equivariance): A learned property where model outputs transform consistently with input transformations, here via data augmentation. "augmented with random rotations to learn stochastic equivariance"
  • Error exposure: The phenomenon where early generation errors propagate and degrade final outputs, especially in autoregressive pipelines. "small levels of atomic noise introduced via error exposure are often sufficient to severely reduce designability."
  • Finite-scalar quantization (FSQ): A simple vector quantization scheme that discretizes continuous latents into finite scalar levels. "We discretize to ĉ using finite-scalar quantization (FSQ) with levels (8,5,5,5) (effective codebook size 1000)"
  • Flow loss: The objective used to train flow-based decoders, typically matching predicted vector fields to ground truth dynamics. "The noised coordinates are used in a flow loss objective"
  • Flow matching: Training a model to approximate the vector field that transports one distribution into another under a flow. "In flow matching, a neural network learns to approximate a vector field corresponding to the flow"
  • gFID: A variant of Fréchet Inception Distance adapted for generative protein distributions, measuring distributional coverage. "We find that taking more tokens reduces designability (more opportunities for error exposure), but improves gFID (distributional coverage)."
  • Global tokenization: Tokenizing an entire structure such that each successive token adds global, coarse-to-fine information. "we pursue the alternative approach of global tokenization, where each token provides additional global context."
  • Manifold-constrained guidance: A guidance technique that limits diffusion steps to stay closer to the data manifold during generation. "This combines limited intervals and manifold constrained guidance (Kynkäänniemi et al., 2024; Chung et al., 2024)"
  • Min-p sampling: A decoding method that restricts generation to tokens with probability above a minimum threshold to balance diversity and coherence. "We use standard nucleus or min-p sampling to generate a sequence of tokens"
  • MLP probing: Evaluating representations by training a small multilayer perceptron on downstream tasks without fine-tuning the base model. "We perform linear and MLP probing on the CATH classification task"
  • Nested dropout: A training technique that enforces an ordering over features by progressively dropping later components. "To impose adaptivity, we uniformly sample an upper cutoff U(1, ... , min(L, kmax)) and apply nested dropout"
  • Nucleus sampling: A decoding method that samples from the smallest set of top-probability tokens whose cumulative probability exceeds a threshold. "We use standard nucleus or min-p sampling to generate a sequence of tokens"
  • ODE-based sampling: Decoding by integrating an ordinary differential equation that follows the learned vector field. "Standard ODE-based sampling integrates the learned vector field"
  • Optimal transport: A framework for comparing and aggregating distributions (e.g., residue-level embeddings) that preserves structure better than mean pooling. "more sophisticated approaches based on optimal transport have been proposed"
  • Posterior collapse: A failure mode where conditional generation ignores inputs, effectively becoming unconditional. "To benchmark against posterior collapse, we also report the fraction of classifier annealed samples with TMscore > 0.5 as compared to no-classifier annealing."
  • Relative positional encodings: Position representations that encode distances between tokens rather than absolute indices. "We use relative positional encodings throughout"
  • RoPE (Rotary Position Embedding): A position encoding mechanism for transformers that uses rotations in embedding space. "An important design detail is the use of absolute positional encodings on the input, rather than RoPE (see Appendix C)."
  • RMSD: Root Mean Square Deviation; a structural similarity metric measuring average distance between corresponding atoms. "We first evaluate APT on reconstruction using RMSD, TM- score, and rFID."
  • SDE: Stochastic Differential Equation; a probabilistic counterpart to ODEs used in diffusion sampling. "It is common to instead integrate the following SDE, which has identical marginals at n = y = 1."
  • Score annealing: Reducing the noise level (or guidance strength) during diffusion to bias sampling toward higher-likelihood regions. "Standard practice is to bias this integration towards higher probability regions by reducing n (score annealing)"
  • SE(3) invariance: Invariance to 3D rotations and translations, critical for modeling molecular structures. "Early works relied heavily on SE(3) invariant losses"
  • Size loss weighting: The weighting coefficient applied to the loss term predicting protein size from tokens. "Size loss weighting: We find a very mild size loss weight (Asize € [0.005, 0.01])"
  • Spline (entropy curve): A smooth curve fit to per-token entropy over time to detect minima for adaptive truncation. "In minimum entropy sampling, we fit a spline to the entropy curve"
  • Teacher forcing: Using ground-truth targets as inputs during training to stabilize sequence generation. "the size is teacher-forced in the diffusion reconstruction."
  • TM-score: A normalized measure of structural similarity between proteins, robust to size differences. "We first evaluate APT on reconstruction using RMSD, TM- score, and rFID."
  • Zero-shot: Performing a task without task-specific training, leveraging generalization from learned representations. "Finally, we demonstrate how our method supports zero-shot protein shrinking and affinity maturation."
  • adaLN (adaptive LayerNorm): A parameter-sharing strategy for LayerNorm that conditions normalization adaptively across layers. "We use relative positional encodings throughout and share adaLN parameters across all decoder layers as done in (Dilip et al., 2025)."
Ai Sparkles Streamline Icon: https://streamlinehq.com View Paper Prompt  List Streamline Icon: https://streamlinehq.com View All Prompts 

Collections

Sign up for free to add this paper to one or more collections.

User Circle Single Streamline Icon: https://streamlinehq.com Sign Up

Tweets

Sign up for free to view the 3 tweets with 90 likes about this paper.

User Circle Single Streamline Icon: https://streamlinehq.com Sign Up for Free